AMBC Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

-0.205

+70.83%

-0.035

-73.08%

-0.025

-88.64%

Estimates Revision

The market is revising No Change the revenue expectations for Octave Specialty Group, Inc. (AMBC) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 2.96%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+2.96%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast AMBC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMBC is 15.00 USD with a low forecast of 15.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 9.030

Low

15.00

Averages

15.00

High

15.00

Current: 9.030

Low

15.00

Averages

15.00

High

15.00

Truist

Buy

maintain

$10 -> $15

2025-11-12

Reason

Truist

Price Target

$10 -> $15

2025-11-12

maintain

Buy

Reason

Truist raised the firm's price target on Ambac Financial to $15 from $10 and keeps a Buy rating on the shares. The firm is updating its model after the company's Q3 earnings beat and its higher assumed organic growth and the ArmadaCare deal, the analyst tells investors in a research note. There should be further upside as Ambac establishes a sustained record of elevated growth, the firm added.

Truist

Mark Hughes

Buy

initiated

$10

2025-07-15

Reason

Truist

Mark Hughes

Price Target

$10

2025-07-15

initiated

Buy

Reason

Truist analyst Mark Hughes initiated coverage of Ambac Financial with a Buy rating and $10 price target. The firm says Ambac is a "rapidly emerging player" in the attractive managing general agent brokerage market. The company now has the resources to grow its insurance distribution operation with the sales of its legacy business on track for the second half of 2025, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Octave Specialty Group Inc (AMBC.N) is -32.25, compared to its 5-year average forward P/E of 19.53. For a more detailed relative valuation and DCF analysis to assess Octave Specialty Group Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

19.53

Current PE

-32.25

Overvalued PE

94.08

Undervalued PE

-55.01

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

6.40

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

30.32

Undervalued EV/EBITDA

-17.53

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

2.10

Current PS

0.00

Overvalued PS

3.65

Undervalued PS

0.54

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

AMBC News & Events

Events Timeline

No data

News

6.0

11-12Benzinga

Truist Securities Keeps Buy Rating on Ambac Financial Group and Increases Price Target to $15

9.5

11-11NASDAQ.COM

Ambac Financial Group (AMBC) Posts Q3 Loss but Exceeds Revenue Projections

4.5

11-10Yahoo Finance

Ambac Financial Group Changes Name to Octave Specialty Group, Inc.

People Also Watch

Frequently Asked Questions

What is Octave Specialty Group Inc (AMBC) stock price today?

The current price of AMBC is 9.03 USD — it has decreased -0.55 % in the last trading day.

What is Octave Specialty Group Inc (AMBC)'s business?

Octave Specialty Group, Inc. is a global specialty insurance company that builds, buys, and scales niche insurance distribution and underwriting businesses. It provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda. Its build-and-buy strategy is executed by its incubation division, Octave Ventures, and its acquisition division, Octave Partners. At Octave Ventures, it helps specialty underwriters to set up their own company, leveraging its resources. It offers funding, infrastructure, risk capital, and A+ rated paper as well as experienced guidance and support to underwriters looking to launch their own MGAs. Octave Partners identifies high-performing MGAs that would benefit from its partnership and add value to its expanding portfolio. To facilitate growth, it provides expertise, technology, distribution and capacity relationships, expansion and cross-company sales opportunities.

What is the price predicton of AMBC Stock?

What is Octave Specialty Group Inc (AMBC)'s revenue for the last quarter?

Octave Specialty Group Inc revenue for the last quarter amounts to 66.61M USD, decreased -4.86 % YoY.

What is Octave Specialty Group Inc (AMBC)'s earnings per share (EPS) for the last quarter?

Octave Specialty Group Inc. EPS for the last quarter amounts to -2.35 USD, increased 273.02 % YoY.

What changes have occurred in the market's expectations for Octave Specialty Group Inc (AMBC)'s fundamentals?

How many employees does Octave Specialty Group Inc (AMBC). have?

Octave Specialty Group Inc (AMBC) has 380 emplpoyees as of December 15 2025.

What is Octave Specialty Group Inc (AMBC) market cap?

Today AMBC has the market capitalization of 578.43M USD.